PATENT CLAIM ANALYSIS

Application Number: 15903279
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.

Claim (Index 1):
A method for the treatment of primary biliary cirrhosis, comprising administering (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof to a patient in need thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.38636
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15496875', '15720849', '15139138', '15271460', '14663027']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6927439182754039
- 35 USC 102 Novelty (BERT): 0.4753754449212553
- Combined Prediction Score: 0.6710070709399891
- Mean Citation Score: 177.44993600000004
- Max Citation Score: 193.82787
- Similarity Product: 163.07767130809663

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test